SEC 13F Intelligence

Global Imc LLC / TGTX

Global Imc LLC’s Tg Therapeutics Inc Position

Does Global Imc LLC own Tg Therapeutics Inc (TGTX)? Not currently — the last reported position was 116.3K shares worth $5M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q1 2025
Shares
116.3K
% of Portfolio
+1.25%
Quarters Held
6
position exited

Position History TGTX

Reported value by quarter
Q2 ’20: $2MQ2 ’20Q3 ’20: $2MQ3 ’20Q4 ’20: $2MQ4 ’20Q1 ’21: $1MQ1 ’21Q4 ’22: $1MQ4 ’22Q1 ’25: $5MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025116.3K$5M+1.25%
Q4 2022108.8K$1M+0.33%
Q1 202128.2K$1M+0.38%
Q4 202032.1K$2M+0.45%
Q3 202065.2K$2M+0.64%
Q2 202096.0K$2M+0.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of TGTX.